Watson v. Edmark

118 F.4th 456
CourtCourt of Appeals for the First Circuit
DecidedSeptember 30, 2024
Docket21-1208
StatusPublished
Cited by2 cases

This text of 118 F.4th 456 (Watson v. Edmark) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Watson v. Edmark, 118 F.4th 456 (1st Cir. 2024).

Opinion

United States Court of Appeals For the First Circuit

No. 21-1208

BRIAN WATSON,

Petitioner, Appellant,

v.

MICHELLE EDMARK, Warden of the New Hampshire State Prison for Men,

Respondent, Appellee.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

[Hon. Joseph N. Laplante, U.S. District Judge]

Before

Barron, Chief Judge, Lipez and Howard, Circuit Judges.

Mark L. Sisti, Sisti Law Offices, for appellant. Elizabeth C. Woodcock, Assistant Attorney General, with whom John M. Formella, Attorney General of New Hampshire, and Anthony J. Galdieri, Solicitor General of New Hampshire, were on brief, for appellee.

September 30, 2024 HOWARD, Circuit Judge. Contending that his

Confrontation Clause rights were violated during his trial in a

New Hampshire court, appellant Brian Watson appeals the district

court's denial of his 28 U.S.C. § 2254 petition for habeas corpus

relief. Watson principally argues that the New Hampshire Supreme

Court made unreasonable factual findings when it affirmed the trial

court's decision to allow the state to present laboratory evidence

through the testimony of a forensic toxicologist who had not

himself conducted the relevant tests. We conclude that Watson has

not established by clear and convincing evidence that the state

court's factual findings were incorrect. We further conclude that,

to the extent that Watson argues that the state court's decision

was contrary to or involved an unreasonable application of Supreme

Court precedent, his appeal on that ground also fails.

I.

Following his trial in 2017, a jury convicted Watson of

felony sale of a controlled drug (fentanyl) with death resulting.

The state's evidence at trial included testimony by Dr. Daniel

Isenschmid, a forensic toxicologist, who explained that testing

conducted by colleagues had revealed a certain level of fentanyl

and its metabolites in the victim's blood. Watson appealed his

conviction, arguing that the trial court erred by, among other

things, allowing Dr. Isenschmid to testify to the results of

- 2 - toxicology tests that he did not perform. State v. Watson, 185

A.3d 845, 847 (N.H. 2018). The New Hampshire Supreme Court

affirmed. Id.

Watson subsequently filed a petition for habeas relief

pursuant to 28 U.S.C. § 2254 in federal district court, asserting

that Dr. Isenschmid's testimony violated Watson's rights under the

Confrontation Clause. The respondent warden of the correctional

facility where Watson is in custody moved for summary judgment.

After a hearing, the district court granted the motion for summary

judgment. This appeal followed.1

Dr. Isenschmid's testimony and the state court's

findings about it bear particular relevance to Watson's plaint, so

we examine them at the outset. Dr. Isenschmid is a forensic

toxicologist for National Medical Services ("NMS"), a private

laboratory based in Pennsylvania that New Hampshire engages for

toxicology screening in connection with forensic autopsies. As

part of the autopsy of the overdose victim in Watson's criminal

case, the office of the state's chief medical examiner sent the

victim's blood and urine samples to NMS for an "expanded

post-mortem toxicology panel."

1 Although Watson's appeal was not timely, the district court granted his unopposed motion for leave to file a late notice of appeal. - 3 - At trial, Dr. Isenschmid gave a general overview of the

process that NMS uses for samples that arrive from out of state.

He testified that, beginning upon arrival, the specimens are

tracked throughout the testing process to record the chain of

custody. Typically, the testing process involves preparing the

samples for analysis, an initial review of the results, and a

secondary review of the results. After the laboratory testing is

complete, a toxicologist -- such as Dr. Isenschmid -- "review[s]

the entire case." Dr. Isenschmid testified that when he reviews

a case, he "look[s] at all the documentation[,] . . . make[s] sure

everything [was] entered properly into the computer

system[,] . . . [and] review[s] all of the instrument tracings" to

ensure that it matches what was reported.

With respect to the sample taken from the victim, Dr.

Isenschmid testified that the toxicology tests identified three

compounds in the victim's blood -- a breakdown of marijuana,

fentanyl, and norfentanyl (a breakdown product of fentanyl) -- and

that the victim's urine tested positive for marijuana and opiates.

He further testified that there were 21 nanograms per milliliter

of fentanyl found in the victim's blood and explained that "since

the fentanyl concentration was so high [and] the norfentanyl

concentration was so low, it could certainly be a reason for an

acute fentanyl death," but noted that this conclusion was

"something that is determined by the medical examiner."

- 4 - In considering the permissibility of Dr. Isenschmid's

testimony, the New Hampshire Supreme Court noted that Dr.

Isenschmid had personally reviewed "all the documentation in the

case," ensured that entries had been made correctly, "reviewed the

actual instrument data" and "all . . . the testing results," and

"issued and signed the toxicology report that described the testing

results and testified that the report accurately reflected his

findings and conclusions." Watson, 185 A.3d at 858 (internal

quotation marks omitted). For these reasons, the state court

concluded that Dr. Isenschmid's "participation in preparing the

report and developing the substantive conclusions contained

therein was real and direct" and that his testimony did not violate

the Confrontation Clause. Id. (quoting State v. Michaels, 95 A.3d

648, 674 (N.J. 2014)).

In its order granting summary judgment to the warden in

the present habeas action, the district court stated that it could

not say that the state court's opinion was "contrary to, or

involved an unreasonable application of, clearly established

federal law as determined by the Supreme Court." And the district

court noted:

The case did not involve unaccompanied testimonial affidavits, certifications, or reports, and did not involve "mere custodian" or "mere conduit" testimony from an analyst or criminologist unconnected with the report

- 5 - (which here was signed by the witness in question) or the work described.

II.

We review the district court's grant of summary judgment

de novo. Lawless v. Steward Health Care Sys., LLC, 894 F.3d 9, 21

(1st Cir. 2018) (citing McKenney v. Mangino, 873 F.3d 75, 80 (1st

Cir. 2017)). "Summary judgment is warranted if the record,

construed in the light most flattering to the nonmovant, 'presents

no genuine issue as to any material fact and reflects the movant's

entitlement to judgment as a matter of law.'" Id. at 20-21

(quoting McKenney, 873 F.3d at 80).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carr v. Lizotte
First Circuit, 2026
State of Maine v. Rochelle Gleason
2025 ME 52 (Supreme Judicial Court of Maine, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
118 F.4th 456, Counsel Stack Legal Research, https://law.counselstack.com/opinion/watson-v-edmark-ca1-2024.